Imaging and molecular biomarkers of vulnerable atheromatous plaques
Xinkang Wang1, J Lynn Rutkowsky, Giora Z Feuerstein
1Wyeth Research, Translational Medicine, 500 Arcola Road, S2324, Collegeville, PA 19426, USA. wangx8@wyeth.com
Abstract:
Rupture of a vulnerable atherosclerotic plaque is the main cause of acute coronary syndromes, myocardial infarction and death. Identification of biomarkers that accurately predict the risk of plaque rupture may be a means to establish and monitor response to therapeutic intervention. This review focuses on recent advances for the use of circulating molecular biomarkers and imaging modalities to assess atherosclerotic vulnerable plaques in both preclinical models and clinical conditions.
Related Concept Videos
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Atherosclerosis I: Introduction
Imaging Studies VII: Vascular Imaging
Imaging Studies for Cardiovascular System III: X-Ray
Definition and Purpose
An X-ray, or radiograph, is a non-invasive method that uses ionizing radiation to take images of internal structures. It is mainly used in cardiac imaging to examine the heart, lungs, and major blood vessels, aiming to identify abnormalities in the heart's size, shape, and position, such as heart failure, congenital defects, and vascular...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Imaging Studies for Cardiovascular System V: CT


